Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA alkylation refers to the covalent addition of alkyl groups to DNA bases or the phosphate backbone, typically induced by exposure to alkylating agents. This chemical modification disrupts DNA structure and function, leading to mutations, cytotoxicity, and genomic instability. It is a fundamental process in toxicology, carcinogenesis, and cancer therapy, where alkylating agents are used to induce lethal DNA damage in rapidly dividing cancer cells.
Covalent modification of DNA leading to disruption of replication and transcription.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA (alkylation).